Alivia Analytics, a leading healthcare payment accuracy solutions provider, has appointed Bill Lucia to its Board of Directors. Lucia will be instrumental in shaping the company’s product roadmap and leveraging his extensive industry experience.
A recognized and respected industry leader, Lucia previously served as the CEO of HMS Holdings, a leading healthcare analytics and technology company serving health plans, providers, and the state and federal government. With his strategic vision, HMS was transformed into a highly successful enterprise and was eventually acquired by Gainwell Technologies and Veritas Capital for $3.4 billion.
“ I’ve been asked to join many boards, but I prefer to focus on those that tackle elemental problems in the healthcare industry. These include health equity, serving those less fortunate, and finding ways to better allocate our federal and state tax dollars to improve people’s lives to save taxpayer dollars,” explained Lucia. “I’m interested in finding companies that address these issues and help to reduce waste in the system.”
Lucia goes on to say: “I am excited to join Alivia’s board, given their strong and proven capabilities in using sophisticated technology, including Machine Learning and Artificial Intelligence, to address the massive problem of fraud, waste, and abuse in healthcare claims. Their purpose-built platform for FWA is the most robust I’ve seen in the industry, covering all payer segments, including commercial and government. Alivia’s dedication to generating fast, actionable insights and their commitment to this critical issue truly sets them apart.”
“We are thrilled to welcome Bill Lucia to our board of directors. His extensive experience and unique insights into the healthcare industry will be invaluable as we continue to evolve and enhance our offerings,” says Mike Taylor, MD, Alivia Analytics CEO. “Alivia is committed to transforming the healthcare payment landscape by leveraging advanced technology and deep industry expertise. With Bill’s guidance, we look forward to further strengthening our capabilities and driving greater value for our clients and the healthcare industry as a whole.”
In addition to joining the Alivia Analytics board, Lucia is currently the Executive Director at Bill Lucia Associates, where he assists healthcare-focused private equity firms and digital health companies in improving work culture through leadership development and advising on go to market strategies. He also mentors digital health CEO’s of early stage companies who share a passion for solving healthcare issues.
Prior to his current postings, Lucia was President, CEO, & Chairman of the Board at HMS. He currently serves on the Board of Directors at At Home Harmony, the Population Health Alliance (PHA), OptMycare, Sellers Dorsey, and the International Advisory Council for ANDHealth, an Australian Digital Health incubator. He previously served as a Board Director at the Australian Digital Health CRC (aka Curana Health).
Bill also co-authored the book “Leading with Your Head and Your Heart,” a detailed account of his journey to transform HMS. Proving that with the best executive team in the business, a workforce with unparalleled passion and commitment to serve, and a handful of brilliant partners, anything is possible when you truly unleash the power of your people.
Health Enterprise Partners and Council Capital
Investments by Council Capital and Health Enterprise Partners (HEP), both healthcare-focused private equity firms, have fueled the nationwide expansion of Alivia’s industry-leading platform.
About Alivia Analytics
Alivia Analytics specializes in payment accuracy solutions for healthcare claim payers / insurers and processors / administrators, leveraging hundreds of years of combined medical, clinical, and law enforcement experience. Alivia’s proprietary, state-of-the-art software rapidly delivers the only seamless analytics solution in the healthcare industry, impacting billions of dollars in fraud, waste, and abuse (FWA). Their purpose-built platform is designed to tackle the $900 billion problem with speed, accuracy, and adaptability, with the lowest false positives in the industry.